Barclays »

Revolution Medicines shares owned by Barclays

Quarter-by-quarter ownership of Revolution Medicines shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.1M 872k 1.26

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Revolution Medicines

Deerfield Management Company
Calamos Advisors
MacKay Shields
Linden Advisors
Zazove Associates
Jpmorgan Chase & Co
BlackRock
Lord, Abbett & Co
M&G
Ameriprise Financial
Franklin Resources
SSI Investment Management
Toronto-Dominion Bank
Millennium Management
FMR

View all funds holding Revolution Medicines